About: R-BL-M-04 Versus R-(DA)-EPOCH and Autologous Stem Cells Transplantation in Patients With High-Grade B-cell Lymphoma Double-hit (HGBL DH) and High-Grade B-cell Lymphoma Not Otherwise Specified (HGBL NOS)

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: R-BL-M-04 Versus R-(DA)-EPOCH and Autologous Stem Cells Transplantation in Patients With High-Grade B-cell Lymphoma Double-hit (HGBL DH) and High-Grade B-cell Lymphoma Not Otherwise Specified (HGBL NOS) Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

clinical trial

Attributes	Values
rdf:type	Item
description	clinical trial (en) ensayu clínicu (ast) klinisch onderzoek (nl) клінічне випробування (uk)
rdfs:label	R-BL-M-04 Versus R-(DA)-EPOCH and Autologous Stem Cells Transplantation in Patients With High-Grade B-cell Lymphoma Double-hit (HGBL DH) and High-Grade B-cell Lymphoma Not Otherwise Specified (HGBL NOS) (en)
skos:prefLabel	R-BL-M-04 Versus R-(DA)-EPOCH and Autologous Stem Cells Transplantation in Patients With High-Grade B-cell Lymphoma Double-hit (HGBL DH) and High-Grade B-cell Lymphoma Not Otherwise Specified (HGBL NOS) (en)
name	R-BL-M-04 Versus R-(DA)-EPOCH and Autologous Stem Cells Transplantation in Patients With High-Grade B-cell Lymphoma Double-hit (HGBL DH) and High-Grade B-cell Lymphoma Not Otherwise Specified (HGBL NOS) (en)
title	wds:Q62811645-DB51AF22-8513-4B06-BC8A-B203DC1D454D
title	Randomized, Controlled (Comparative), Open, Prospective Study Evaluating an Efficacy of R-DA-EPOCH-21, R-BL-M-04 and Autologous Stem Cells Transplantation in Patients With High-Grade B-cell Lymphoma Double-hit and High-Grade B-cell Lymphoma Not Otherwise Specified (en)
end time	wds:Q62811645-59BEC382-7D4E-4243-9383-1B5E5228BAD5
end time	2021-03-15 00:00:00Z (xsd:dateTime)
instance of	wds:Q62811645-C350E325-DE17-4B3D-B0D2-062B6754FF61
instance of	clinical trial
start time	wds:Q62811645-0EC1AFC0-BE58-4F2B-AD93-EF753B6A60CB
start time	2018-03-15 00:00:00Z (xsd:dateTime)
research intervention	wds:Q62811645-1DB0AEAE-F1C3-4221-8EBB-063F6351371A wds:Q62811645-22F7BA66-4D05-4137-9487-DA76C77E6811 wds:Q62811645-463865AA-6930-49DF-BDE0-35F2A83C7832 wds:Q62811645-56612469-F66C-4BE3-A414-ACAD0E4456CF wds:Q62811645-E65C337B-3CE6-4D1C-9CAC-41C70F88F2BB
research intervention	(RS)-cyclophosphamide wd:Q18936 wd:Q418817 vincristine prednisone
minimum age	wds:Q62811645-70FBC468-00DC-43C8-BDEF-264611178CDC
minimum age	18 (xsd:decimal)
medical condition	wds:Q62811645-8D058869-087C-40E1-B815-84564BFC8254
medical condition	lymphoma
number of participants	wds:Q62811645-F6112FBD-8015-420D-874A-D3D742453783
number of participants	80 (xsd:decimal)
maximum age	wds:Q62811645-C7ACA092-2CBB-4001-ACBE-1140B118F21E
maximum age	60 (xsd:decimal)
study type	wds:Q62811645-584774B4-0D7D-4B43-A8AF-C1D8337ACC5F
study type	interventional study
ClinicalTrials.gov ID	wds:Q62811645-5819B22D-1DDD-47C9-9966-BBC222F91D66
ClinicalTrials.gov ID	NCT03479918
clinical trial phase	wds:Q62811645-BF7C4CD9-7849-415F-83D5-C4CB451B4BBF
clinical trial phase	phase III clinical trial
research subject recruitment status	wds:Q62811645-40369862-EF4C-42F5-A235-ECB2DAEDAA45
research subject recruitment status	recruiting
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q62811645

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software